Views: 0 Author: Xiaoying Publish Time: 2026-06-25 Origin: Site
Xylitol is one of the most recognized sugar alcohols in oral care. Erythritol is less familiar to many consumers, but it has attracted interest because of its low cariogenic potential, clean sensory profile, low hygroscopicity, and emerging oral-biofilm research.
For brand owners and formulators, the useful question is not simply which polyol has the strongest headline. It is which ingredient better fits the product format, sensory target, manufacturing process, intended use, evidence package, and destination-market claims.
This guide compares xylitol and erythritol for toothpaste, toothpaste tablets, tooth powder, mouthwash, chewing gum, lozenges, and other oral care formulas.
Xylitol is usually the better default choice when a brand wants strong consumer recognition, approximately sugar-like sweetness, broad oral-care precedent, and easy use across toothpaste and mouthwash. Erythritol may be the better formulation choice for dry tablets or powders that need low hygroscopicity, a less sweet profile, or a differentiated ingredient story—provided its lower sweetness, cooling effect, solubility, and crystallization behavior are managed.
Neither ingredient should be marketed as an anticavity active solely because it appears in the formula.
Choose xylitol for familiar oral-care positioning, stronger sweetness, flavor support, and a larger body of chewing-gum and dental-product literature.
Choose erythritol for dry-format stability, lower sweetness, a clean cooling sensation, and a less crowded marketing story.
Consider a xylitol–erythritol blend only after testing. In-vitro research has reported strain-dependent and mixed combination effects, so synergy should not be assumed.
For caries prevention, fluoride or another legally supported active system, brushing behavior, contact time, and the complete product evidence remain more important than the sweetener name alone.
Decision Factor | Xylitol | Erythritol | Brand Implication |
|---|---|---|---|
Relative sweetness | Close to sucrose in perceived sweetness | Less sweet than sucrose and usually less sweet than xylitol | Erythritol may need flavor or secondary-sweetener support |
Cooling sensation | Noticeable cooling effect | Often a strong, clean cooling effect | Useful for mint concepts but can become sharp at high levels |
Water behavior | Generally more soluble and more moisture-responsive | Lower hygroscopicity but lower aqueous solubility | Xylitol suits liquids; erythritol can suit dry formats but may crystallize in liquids |
Oral-care recognition | High consumer and professional recognition | Emerging and less familiar | Xylitol is easier to explain; erythritol can differentiate |
Evidence base | Larger body of gum, lozenge, toothpaste, and microbiology research | Smaller but growing body of clinical and biofilm research | Evidence must be matched to the exact dosage form |
Streptococcus mutans | Non-fermentable; research suggests effects on growth, adhesion, acid production, and biofilm under defined conditions | Non-fermentable; in-vitro studies show strain- and concentration-dependent biofilm inhibition | Neither result automatically proves finished-product efficacy |
GI exposure | Excess swallowed polyol can cause gastrointestinal discomfort | Often better tolerated at food-use doses, but exposure still requires assessment | Important for gums, lozenges, chewables, and children's products |
Pet-safety risk | Xylitol is dangerous to dogs if ingested | Does not carry the same established canine xylitol hazard | Xylitol brands need strong household risk controls |
Xylitol and erythritol are polyols, often called sugar alcohols. Unlike sucrose, they are not readily fermented by common cariogenic oral bacteria into the same acid load. Replacing fermentable sugar with a non-fermentable sweetener can therefore reduce one driver of plaque pH decline.
That basic sugar-replacement effect should be separated from stronger claims such as “kills cavity bacteria,” “prevents cavities,” or “remineralizes enamel.” Those claims require evidence and may change product classification.
Xylitol has been studied for its interaction with mutans streptococci, including Streptococcus mutans. Proposed effects include reduced acid production from xylitol itself, interference with bacterial energy metabolism, and changes in adhesion or biofilm structure under certain exposure conditions.
However, responses vary by bacterial strain, dose, delivery format, frequency, and study method. A six-month cluster-randomized trial found that a low-strength xylitol/fluoride toothpaste was not more effective than a fluoride-only control for early childhood caries. This is an important formulation lesson: xylitol may contribute useful properties, but it should not be treated as a replacement for a proven anticaries active.
Erythritol is also not readily fermented by cariogenic bacteria. Laboratory studies have reported inhibition of S. mutans growth or biofilm development at defined concentrations, although effects vary among strains and models.
A real-time biofilm study using nine S. mutans strains found that both xylitol and erythritol inhibited biofilm formation, with different strains showing different sensitivities. Another in-vitro study found dose-dependent effects but no bactericidal action, and mixed results when the two polyols were combined.
For brand owners, this means that erythritol is scientifically relevant, but “emerging evidence” is more accurate than claiming universal superiority.
The answer depends heavily on product format and study design.
A three-year randomized trial in 485 schoolchildren compared candies providing approximately 7.5 g per day of erythritol, xylitol, or sorbitol. The erythritol group showed fewer dentin caries outcomes at selected follow-ups and longer times to lesion development or progression than the xylitol and sorbitol groups.
This is relevant evidence for a repeatedly consumed confectionery format. It does not establish that erythritol toothpaste at a much lower exposure will outperform xylitol toothpaste.
A separate school lozenge program using xylitol/maltitol or erythritol/maltitol did not find a statistically significant caries reduction in a low-caries population after follow-up. Differences in baseline risk, formulation, polyol blend, exposure duration, and adherence can change the result.
Xylitol toothpaste studies are also mixed. A cluster-randomized trial comparing fluoride–xylitol toothpaste with a fluoride–sorbitol control did not show superior caries prevention for the xylitol formula after six months. An in-vitro enamel study reported improved remineralization for a 500 ppm fluoride toothpaste containing 5% xylitol compared with tested controls, but laboratory remineralization does not replace clinical evidence.
The practical conclusion is that no single study supports a universal “best polyol” across every oral-care product.
There is no universal evidence-based xylitol or erythritol percentage that works across toothpaste, mouthwash, tablets, gum, and lozenges.
Clinical polyol studies often use multiple daily exposures and gram-level intake. The three-year erythritol study used candies three times per school day, totaling about 7.5 g of polyol daily. A toothpaste is used briefly and expectorated; a mouthwash has a defined rinse volume and contact time; a lozenge dissolves gradually and may be swallowed.
Those exposure profiles are not interchangeable.
Ask whether the polyol is being used primarily for:
Sweetness and flavor balancing
Cooling sensation
Humectancy or solids contribution
Tablet or powder processing
Sugar-free positioning
Saliva-stimulating chewing-gum or lozenge use
A specific oral-health claim supported by the finished product
The percentage should then be selected through pilot formulation, sensory testing, stability, microbiology, process validation, and market-specific claim review.
Gum, lozenges, chewable tablets, and children's products can create meaningful daily gastrointestinal exposure. Serving size, maximum daily use, accidental overconsumption, age group, and warning language must be considered. For non-swallowed toothpaste and mouthwash, the safety assessment should still account for foreseeable ingestion.
Xylitol provides sweetness close to sucrose and a noticeable cooling effect. It can support mint, fruit, children's, and mild-flavor formulas while reducing reliance on intense sweeteners.
Potential formulation challenges include:
Excess cooling in already strong mint systems
Moisture uptake in tablets or powders
Stickiness or softening in humid conditions
Texture and water-activity changes at higher levels
A sweetness profile that may not suit minimalist adult formulas
Erythritol is less sweet and can create a clean, pronounced cooling sensation. It may fit premium mint, dry tablet, powder, and low-sweetness concepts.
Potential challenges include:
Insufficient sweetness when used alone
Crystallization or sediment risk in concentrated aqueous formulas
Grittiness if particle size and dissolution are not controlled
A sharp cooling curve at high levels
Need for a secondary sweetener, which changes the label and sensory system
Blind sensory testing should measure sweetness onset, bitterness masking, cooling intensity, aftertaste, mouth coating, dissolution, and repeat-use preference—not just first-sample acceptance.
Product Format | Usually Better Starting Point | Why | Main Validation Needed |
|---|---|---|---|
Conventional toothpaste | Xylitol | Familiar positioning, strong sweetness, water compatibility, broad formulation precedent | Fluoride/active compatibility, rheology, microbial quality, sensory, claim support |
Toothpaste tablets | Erythritol or a tested blend | Low hygroscopicity can support dry-format stability; clean cooling profile | Compression, friability, moisture uptake, bite, disintegration, crystallinity, flavor |
Tooth powder | Erythritol | Dry processing and lower moisture response can be advantageous | Particle size, dust, segregation, dissolution, abrasivity, sensory |
Ready-to-use mouthwash | Xylitol | Generally easier aqueous formulation and stronger sweetness | Clarity, pH, preservation, flavor solubilization, packaging compatibility |
Concentrated mouthwash | Xylitol or blend | Solubility and sweetness may help, but concentration raises crystallization and osmotic issues | Dilution behavior, low-temperature stability, dose accuracy, microbial control |
Gum or lozenge | Depends on evidence and dose | Both have clinical precedent in consumed formats | Daily dose, contact time, GI tolerance, texture, claims, pet/child safety |
Children's oral care | Xylitol is easier to recognize; either may work | Flavor acceptance and non-cariogenic sweetness are useful | Fluoride dosing, foreseeable swallowing, age suitability, warnings, evidence |
These are development starting points, not fixed rules. A validated formula can justify a different choice.
Yes, a blend can combine xylitol's sweetness and solubility with erythritol's lower hygroscopicity and clean cooling profile. It may also help tune tablet compression, dissolution, and flavor release.
However, do not market the combination as synergistic without direct evidence. An in-vitro study of S. mutans and S. sobrinus found mixed combination outcomes, ranging from possible additive effects to indifference or possible antagonism depending on the strain.
A blend should be justified by measurable product benefits:
Better sensory balance
Improved tablet processing
Lower moisture pickup
Faster or more controlled dissolution
Stable liquid clarity
Acceptable cost and sourcing
Evidence matching the final product
EU Regulation (EU) No 432/2012 includes authorized food health claims for sugar replacers, including xylitol and erythritol, under specific conditions. One claim concerns maintenance of tooth mineralization when sugar is replaced in foods or drinks and plaque pH conditions are met.
Those food claims do not automatically apply to toothpaste, mouthwash, cosmetics, or medical products. Oral-care product claims must be assessed under the product's actual regulatory category, formulation, directions, and destination market.
An EFSA assessment of a proposed claim for sugar-free hard confectionery containing at least 90% erythritol concluded that the evidence was insufficient to establish the claimed reduction in dental plaque linked to caries risk. This reinforces the need to match claims to the complete evidence package.
In the United States, intended use determines whether a product is a cosmetic, drug, or both. A toothpaste marketed only for cleansing may follow a different route from one claiming to prevent cavities or treat disease. Adding xylitol or erythritol does not by itself authorize an anticavity claim.
For fluoride toothpaste and therapeutic claims, the active ingredient, labeling, testing, and regulatory pathway must be reviewed separately from the sweetener system.
The FDA warns that xylitol is toxic to dogs. Brands using xylitol should evaluate household storage, packaging security, consumer education, complaint handling, and accidental-ingestion messaging—especially for flavored toothpaste, tablets, gum, and lozenges.
Test or Document | Xylitol-Specific Focus | Erythritol-Specific Focus |
|---|---|---|
Raw-material qualification | Identity, assay, particle size, moisture, microbial quality | Identity, assay, particle size, crystallinity, moisture, microbial quality |
Formula compatibility | Active compatibility, humectancy, water activity, viscosity | Solubility, precipitation, recrystallization, grittiness, active compatibility |
Sensory testing | Sweetness, cooling, aftertaste, stickiness | Lower sweetness, cooling intensity, dissolution, gritty perception |
Stability testing | Moisture uptake, texture, flavor, microbial quality | Crystal growth, sediment, texture, dissolution, flavor, microbial quality |
Finished-product performance | Dose delivery, brushing/rinsing behavior, tablet integrity | Dose delivery, dissolution, tablet integrity, clarity where applicable |
Claims substantiation | Evidence bridge to the exact formula, dose, format, and directions | Evidence bridge to the exact formula, dose, format, and directions |
Safety assessment | Foreseeable ingestion, GI exposure, canine household hazard | Foreseeable ingestion and GI exposure |
Brand owners should request the final quantitative formula, ingredient specifications and COAs, process controls, stability protocol and report, microbiological results, packaging-compatibility data, sensory report, safety-assessment inputs, and a written claims rationale.
Non-fermentability and laboratory antimicrobial findings do not automatically authorize an anticavity claim.
Ingested candies and briefly used toothpaste have different doses, contact times, saliva stimulation, and compliance patterns.
The sweetener should be evaluated as part of the total formula. It should not distract from the evidence and regulatory status of fluoride, hydroxyapatite, or another primary active direction.
Erythritol can be attractive in dry products but may create crystal or sediment issues in liquids if poorly designed.
Packaging and consumer communication should account for serious accidental ingestion risk to dogs.
Use a blend for demonstrated formulation or sensory advantages unless finished-product evidence proves more.
What role will the polyol perform: sweetness, humectancy, processing, sugar replacement, or claim support?
Why is xylitol, erythritol, or a blend better for this dosage form?
What concentration range was screened during development, and which acceptance criteria were used?
How does the polyol affect the main active ingredient, pH, water activity, rheology, and preservation?
For dry formats, what moisture, compression, friability, and dissolution data are available?
For liquids, what solubility, low-temperature, precipitation, and clarity data are available?
What sensory panel method was used?
Does the evidence support the exact finished product and directions?
Which claims are permitted in each target market?
How is foreseeable swallowing evaluated for children or consumed formats?
What xylitol pet-safety controls are recommended?
Which raw-material, formula, or process changes require revalidation?
Not universally. One long-term candy trial favored erythritol, while other studies found no clear difference or used different products and populations. The result cannot be transferred automatically to toothpaste or mouthwash.
Xylitol is generally described as non-fermentable and may interfere with growth, acid production, adhesion, or biofilm behavior under defined conditions. It should not be described as universally bactericidal, and effects vary by strain and exposure.
Yes. It can provide sweetness, cooling, and solids contribution. Its solubility, particle size, crystallization, grittiness, and interaction with the active system must be tested.
Erythritol is often a useful starting point because of its low hygroscopicity, while xylitol provides stronger sweetness and familiar positioning. The better choice depends on compression, moisture stability, bite, dissolution, and flavor testing.
No automatic replacement should be assumed. Fluoride has a distinct anticaries role and regulatory framework. Any fluoride-free or alternative-active product needs its own evidence and market-specific claims review.
There is no universal percentage. The correct level depends on product format, intended function, daily exposure, sensory target, active system, stability, safety, and legal claim. Gram-level chewing-gum or candy studies should not be converted directly into a toothpaste percentage.
For conventional toothpaste and ready-to-use mouthwash, xylitol is usually the more practical default because it offers strong sweetness, consumer familiarity, broad formulation precedent, and a larger oral-care evidence base.
For toothpaste tablets, tooth powder, and differentiated low-sweetness concepts, erythritol can be the stronger formulation option, particularly when low hygroscopicity and dry-format performance matter.
The best product may also use a tested blend. But the commercial decision should be based on the final formula—not a single ingredient story. Evaluate the main active system, dose format, contact time, sensory profile, stability, foreseeable ingestion, target-market claims, and evidence together.
Qiaoerna supports custom and private label oral care development across toothpaste, toothpaste tablets, tooth powder, mouthwash, and concentrated formats. Brands comparing active systems can also read our fluoride vs nano hydroxyapatite vs fluoride-free toothpaste tablet guide and our zero-waste oral care product comparison.

